Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer

Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer

US Patent 12195551 · Granted Jan 14, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cell2025
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cell2025
Antibody that binds ErbB-2 and ErbB-32024
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells2023
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells2023
Antibodies that bind EGFR and cMET2023
Bispecific anti PD1-anti TIM3 antibodies2023
Antibodies that modulate a biological activity expressed by a cell2023
Binding molecules that bind CD137 and PD-L12023
Binding molecules that modulate a biological activity expressed by a cell2023
Antibody that binds ErbB-2 and ErbB-32022
Biological materials related to CXCR72018